Folding of peptide models of collagen and misfolding in disease.

The misfolding of the triple helix has been shown to play a critical role in collagen diseases. Normal and mutated collagen triple helices can be modeled by short, synthetic peptides of varying design. NMR spectroscopy and circular dichroism studies on the assembly of these peptide models have recently been used to isolate specific steps in the folding pathway and have provided information on the alterations resulting from mutations.

[1]  J. Baum,et al.  Two-dimensional NMR assignments and conformation of (Pro-Hyp-Gly)10 and a designed collagen triple-helical peptide. , 1993, Biochemistry.

[2]  H. Berman,et al.  Disrupted collagen architecture in the crystal structure of a triple-helical peptide with a Gly-->Ala substitution. , 1996, Connective tissue research.

[3]  J. Engel,et al.  The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. , 1991, Annual review of biophysics and biophysical chemistry.

[4]  K. Piez,et al.  Equilibrium and kinetic studies of the helix-coil transition in alpha 1-CB2, a small peptide from collagen. , 1970, Biochemistry.

[5]  J. Ramshaw,et al.  A host-guest set of triple-helical peptides: stability of Gly-X-Y triplets containing common nonpolar residues. , 1996, Biochemistry.

[6]  J. Ramshaw,et al.  The collagen triple-helix structure. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[7]  B. Brodsky,et al.  Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides. , 1997, Biochemistry.

[8]  P. Byers,et al.  The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix. , 1991, The Journal of biological chemistry.

[9]  J. Baum,et al.  Backbone dynamics of (Pro-Hyp-Gly)10 and a designed collagen-like triple-helical peptide by 15N NMR relaxation and hydrogen-exchange measurements. , 1993, Biochemistry.

[10]  K. Nagata,et al.  Hsp47: a collagen-specific molecular chaperone. , 1996, Trends in biochemical sciences.

[11]  H. Bächinger.  The influence of peptidyl-prolyl cis-trans isomerase on the in vitro folding of type III collagen. , 1987, The Journal of biological chemistry.

[12]  N. Bulleid,et al.  The C‐propeptide domain of procollagen can be replaced with a transmembrane domain without affecting trimer formation or collagen triple helix folding during biosynthesis , 1997, The EMBO journal.

[13]  K. Mayo,et al.  Cell adhesion promoting peptide GVKGDKGNPGWPGAP from the collagen type IV triple helix: cis/trans proline-induced multiple 1H NMR conformations and evidence for a KG/PG multiple turn repeat motif in the all-trans proline state. , 1991, Biochemistry.

[14]  K. Kivirikko,et al.  Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[15]  D. Prockop,et al.  Perspectives on the synthesis and application of triple-helical, collagen-model peptides. , 1996, Biopolymers.

[16]  R. Freedman,et al.  Defective co-translational formation of disulphide bonds in protein disulphide-isomerase-deficient microsomes , 1988, Nature.

[17]  D J Prockop,et al.  Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.

[18]  Dill,et al.  Folding and binding. , 1996, Current opinion in structural biology.

[19]  M. Mottes,et al.  Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone. , 1994, The Journal of biological chemistry.

[20]  J. Baum,et al.  Nuclear magnetic resonance and circular dichroism studies of a triple-helical peptide with a glycine substitution. , 1992, Journal of molecular biology.

[21]  S. Weiner,et al.  Ultrastructural studies of bones from patients with osteogenesis imperfecta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[22]  P. Byers,et al.  Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule. , 1992, The Journal of biological chemistry.

[23]  S. Saga,et al.  The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta , 1998, The Journal of pathology.

[24]  G. Melacini,et al.  Collagen-based structures containing the peptoid residue N-isobutylglycine (Nleu): synthesis and biophysical studies of Gly-Nleu-Pro sequences by circular dichroism and optical rotation. , 1997, Biochemistry.

[25]  M. Raghunath,et al.  Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. , 1994, Journal of molecular biology.

[26]  P. Privalov.  Stability of proteins. Proteins which do not present a single cooperative system. , 1982, Advances in protein chemistry.

[27]  R. Timpl,et al.  Three Conformationally Distinct Domains in the Amino-Terminal Segment of Type III Procollagen and Its Rapid Triple Helix ⇄ Coil Transition , 1978 .

[28]  R. Timpl,et al.  Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. , 1980, European journal of biochemistry.

[29]  J. Marini,et al.  Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. , 1993, The Journal of biological chemistry.

[30]  N. Bulleid,et al.  Thiol-independent interaction of protein disulphide isomerase with type X collagen during intra-cellular folding and assembly. , 1998, The Biochemical journal.

[31]  N. Bulleid,et al.  Identification of the molecular recognition sequence which determines the type‐specific assembly of procollagen , 1997, The EMBO journal.

[32]  W. Bode,et al.  Design and synthesis of heterotrimeric collagen peptides with a built‐in cystine‐knot Models for collagen catabolism by matrix‐metalloproteases , 1996, FEBS letters.

[33]  K. Doege,et al.  Folding of carboxyl domain and assembly of procollagen I. , 1986, The Journal of biological chemistry.

[34]  P. Byers,et al.  Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. , 1992, The Journal of biological chemistry.

[35]  H. Scheraga,et al.  Free energy of hydration of collagen models and the enthalpy of the transition between the triple‐helical coiled‐coil and single‐stranded conformations , 1989, Biopolymers.

[36]  R. Raines,et al.  Inductive Effects on the Energetics of Prolyl Peptide Bond Isomerization: Implications for Collagen Folding and Stability. , 1996, Journal of the American Chemical Society.

[37]  P. Byers,et al.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II , 1985, Nature.

[38]  P. Byers,et al.  Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite. , 1995, The Biochemical journal.

[39]  H. Kuivaniemi,et al.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels , 1997, Human mutation.

[40]  J. Baum,et al.  Direct NMR measurement of folding kinetics of a trimeric peptide. , 1996, Biochemistry.

[41]  J. Ramshaw,et al.  Sequence Dependence of the Folding of Collagen-like Peptides , 1999, The Journal of Biological Chemistry.

[42]  J. Baum,et al.  Nuclear magnetic resonance shows asymmetric loss of triple helix in peptides modeling a collagen mutation in brittle bone disease. , 1998, Biochemistry.

[43]  J. Baum,et al.  Real-time NMR investigations of triple-helix folding and collagen folding diseases. , 1997, Folding & design.

[44]  H. Kuivaniemi,et al.  Mutations in collagen genes: causes of rare and some common diseases in humans , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  F. Crick,et al.  The molecular structure of collagen. , 1961, Journal of molecular biology.

[46]  C. Levene.  Book Review: Treatise on Collagen , 1969 .

[47]  N. Morris,et al.  Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. , 1993, American journal of medical genetics.

[48]  J. Baum,et al.  Characterization of collagen-like peptides containing interruptions in the repeating Gly-X-Y sequence. , 1993, Biochemistry.

[49]  H. Bächinger,et al.  Thermal stability and folding of type IV procollagen and effect of peptidyl-prolyl cis-trans-isomerase on the folding of the triple helix. , 1989, The Journal of biological chemistry.

[50]  Beat Steinmann,et al.  Connective tissue and its heritable disorders —Molecular, genetic and medical aspects , 1993 .

[51]  K. Beck,et al.  Triple Helix Formation of Procollagen Type I Can Occur at the Rough Endoplasmic Reticulum Membrane* , 1996, The Journal of Biological Chemistry.

[52]  H M Berman,et al.  Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. , 1994, Science.

[53]  N. Bulleid,et al.  Molecular recognition in procollagen chain assembly. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[54]  N. Bulleid,et al.  Protein disulfide Isomerase Acts as a Molecular Chaperone during the Assembly of Procollagen* , 1998, The Journal of Biological Chemistry.